Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector

Positive clinical trial results for Merck & Co’s MRK experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker’s stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. Merck shares jumped as much as 12.3% and hit their highest level since Continue Reading